303.71

2.01% 5.99

After Hours: 303.71

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $303.71, with a volume of 220.24K. It is up +2.01% in the last 24 hours and up +8.34% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$297.72

Open:

$300.2

24h Volume:

220.24K

Relative Volume:

0.89

Market Cap:

$6.68B

Revenue:

$2.58B

Net Income/Loss:

$-778.69M

P/E Ratio:

-11.11

EPS:

-27.33

Net Cash Flow:

$223.75M

1W Performance:

-1.77%

1M Performance:

+8.34%

6M Performance:

+23.56%

1Y Performance:

-9.86%

1-Day Range:

$297.57

$306.81

1-Week Range:

$292.56

$311.43

52-Week Range:

$211.43

$387.99

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1142)

Industry

Medical Devices (146)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,700

Twitter

@BioRadLifeSci

Next Earnings Date

2024-10-30

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	303.71	8.06B	2.58B	-778.69M	223.75M	-27.33
ABT Abbott Laboratories	131.38	230.73B	43.11B	13.94B	6.78B	7.9963
BSX Boston Scientific Corp	94.95	141.37B	18.49B	2.50B	3.49B	1.6801
SYK Stryker Corp	364.92	139.39B	23.82B	2.92B	4.02B	7.5574
MDT Medtronic Plc	95.58	122.43B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	72.95	43.41B	5.69B	1.41B	577.90M	6.9828

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

10:28 AM

Why ETFs are accumulating Bio Rad Laboratories Inc. Class B stockEarnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com

10:28 AM

09:41 AM

Top chart patterns to watch in Bio Rad Laboratories Inc.Wall Street Watch & Fast Gaining Stock Strategy Reports - newser.com

09:41 AM

09:33 AM

Is Bio Rad Laboratories Inc. a candidate for recovery playGap Up & Weekly Momentum Stock Picks - newser.com

09:33 AM

08:30 AM

Does Bio Rad Laboratories Inc. qualify in momentum factor screeningQuarterly Trade Review & Reliable Breakout Forecasts - newser.com

08:30 AM

08:01 AM

How strong is Bio Rad Laboratories Inc. stock balance sheetEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

08:01 AM

05:35 AM

Is Bio Rad Laboratories Inc. stock a bargain at current levelsRate Cut & Free Fast Gain Swing Trade Alerts - newser.com

05:35 AM

03:31 AM

Hydroxyapatite Market to Witness Significant Growth from 2025 - openPR.com

03:31 AM

01:38 AM

Using Bollinger Bands to evaluate Bio Rad Laboratories Inc.Weekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com

01:38 AM

Oct 12, 2025

Bio-Rad offers to acquire digital PCR developer Stilla Technologies - MSN

Oct 12, 2025

How buyback programs support Bio Rad Laboratories Inc. Class B stockJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 12, 2025

What institutional flow reveals about Bio Rad Laboratories Inc.Trade Exit Summary & High Return Trade Opportunity Guides - newser.com

Oct 12, 2025

Sivik Global Healthcare LLC Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Oct 12, 2025

Can Bio Rad Laboratories Inc. (BUW) stock resist broad market declinesJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com

Oct 12, 2025

Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 15.3%Here's What Happened - MarketBeat

Oct 12, 2025

Oct 11, 2025

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpWhat's Next? - MarketBeat

Oct 11, 2025